Evaluation of the convenience of changing the rivastigmine administration route in patients with Alzheimer disease
Evaluación de la conveniencia del cambio de vía de administración de rivastigmina en pacientes con enfermedad de Alzheimer
R. Blesa Gonzáleza,
, M. Boada Rovirab, C. Martínez Parrac, D. Gil-Saladiéd, C.A. Almagroe, A.L. Gobartt Vázquezf, In representation of the kAPA Study research group ◊
Corresponding author
a Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
b Servicio de Neurología, Hospital Universitari Vall d’Hebron, Barcelona, Spain
c Servicio de Neurología, Hospital Virgen de la Macarena, Sevilla, Spain
d Servicio de Neurología, Hospital del Sagrat Cor de Martorell, Martorell, Spain
e Servicio de Neurología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
f Departamento Médico, Novartis Farmacéutica, S.A, Barcelona, Spain
Read
2310
Timeswas read the article
952
Total PDF
1358
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 47 | 8 | 55 |
| 2025 11 | 242 | 26 | 268 |
| 2025 10 | 31 | 17 | 48 |
| 2025 9 | 17 | 34 | 51 |
| 2025 8 | 30 | 30 | 60 |
| 2025 7 | 101 | 13 | 114 |
| 2025 6 | 31 | 4 | 35 |
| 2025 5 | 18 | 7 | 25 |
| 2025 4 | 17 | 6 | 23 |
| 2025 3 | 30 | 10 | 40 |
| 2025 2 | 8 | 3 | 11 |
| 2025 1 | 11 | 24 | 35 |
| 2024 12 | 11 | 8 | 19 |
| 2024 11 | 12 | 8 | 20 |
| 2024 10 | 7 | 10 | 17 |
| 2024 9 | 4 | 10 | 14 |
| 2024 8 | 8 | 6 | 14 |
| 2024 7 | 5 | 3 | 8 |
| 2024 6 | 6 | 6 | 12 |
| 2024 5 | 7 | 14 | 21 |
| 2024 4 | 8 | 15 | 23 |
| 2024 3 | 13 | 14 | 27 |
| 2024 2 | 11 | 9 | 20 |
| 2024 1 | 13 | 15 | 28 |
| 2023 12 | 9 | 30 | 39 |
| 2023 11 | 9 | 32 | 41 |
| 2023 10 | 6 | 12 | 18 |
| 2023 9 | 3 | 1 | 4 |
| 2023 8 | 10 | 7 | 17 |
| 2023 7 | 20 | 27 | 47 |
| 2023 6 | 19 | 12 | 31 |
| 2023 5 | 11 | 5 | 16 |
| 2023 4 | 26 | 0 | 26 |
| 2023 3 | 18 | 5 | 23 |
| 2023 2 | 15 | 1 | 16 |
| 2023 1 | 3 | 6 | 9 |
| 2022 12 | 5 | 6 | 11 |
| 2022 11 | 17 | 9 | 26 |
| 2022 10 | 10 | 12 | 22 |
| 2022 9 | 5 | 20 | 25 |
| 2022 8 | 9 | 12 | 21 |
| 2022 7 | 8 | 10 | 18 |
| 2022 6 | 9 | 10 | 19 |
| 2022 5 | 8 | 6 | 14 |
| 2022 4 | 10 | 6 | 16 |
| 2022 3 | 6 | 12 | 18 |
| 2022 2 | 5 | 4 | 9 |
| 2022 1 | 4 | 7 | 11 |
| 2021 12 | 3 | 8 | 11 |
| 2021 11 | 8 | 14 | 22 |
| 2021 10 | 12 | 22 | 34 |
| 2021 9 | 22 | 16 | 38 |
| 2021 8 | 31 | 9 | 40 |
| 2021 7 | 36 | 8 | 44 |
| 2021 6 | 20 | 9 | 29 |
| 2021 5 | 8 | 6 | 14 |
| 2021 4 | 21 | 11 | 32 |
| 2021 3 | 9 | 7 | 16 |
| 2021 2 | 11 | 5 | 16 |
| 2021 1 | 3 | 15 | 18 |
| 2020 12 | 7 | 2 | 9 |
| 2020 11 | 6 | 6 | 12 |
| 2020 10 | 7 | 3 | 10 |
| 2020 9 | 8 | 14 | 22 |
| 2020 8 | 11 | 11 | 22 |
| 2020 7 | 8 | 5 | 13 |
| 2020 6 | 5 | 2 | 7 |
| 2020 5 | 4 | 9 | 13 |
| 2020 4 | 8 | 4 | 12 |
| 2020 3 | 4 | 2 | 6 |
| 2020 2 | 5 | 6 | 11 |
| 2020 1 | 13 | 9 | 22 |
| 2019 12 | 14 | 14 | 28 |
| 2019 11 | 5 | 8 | 13 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 4 | 6 | 10 |
| 2019 8 | 1 | 1 | 2 |
| 2019 7 | 2 | 10 | 12 |
| 2019 6 | 4 | 17 | 21 |
| 2019 5 | 17 | 43 | 60 |
| 2019 4 | 2 | 7 | 9 |
| 2019 3 | 1 | 4 | 5 |
| 2019 2 | 1 | 7 | 8 |
| 2019 1 | 1 | 1 | 2 |
| 2018 12 | 1 | 3 | 4 |
| 2018 11 | 1 | 4 | 5 |
| 2018 10 | 6 | 11 | 17 |
| 2018 9 | 3 | 2 | 5 |
| 2018 8 | 0 | 5 | 5 |
| 2018 7 | 1 | 1 | 2 |
| 2018 6 | 2 | 2 | 4 |
| 2018 5 | 1 | 3 | 4 |
| 2018 4 | 1 | 1 | 2 |
| 2018 2 | 0 | 1 | 1 |
| 2018 1 | 1 | 1 | 2 |
| 2017 12 | 4 | 0 | 4 |
| 2017 11 | 6 | 1 | 7 |
| 2017 10 | 4 | 0 | 4 |
| 2017 9 | 5 | 5 | 10 |
| 2017 8 | 9 | 6 | 15 |
| 2017 7 | 5 | 0 | 5 |
| 2017 6 | 8 | 18 | 26 |
| 2017 5 | 6 | 3 | 9 |
| 2017 4 | 4 | 3 | 7 |
| 2017 3 | 5 | 5 | 10 |
| 2017 2 | 4 | 0 | 4 |
| 2017 1 | 1 | 0 | 1 |
| 2016 12 | 10 | 0 | 10 |
| 2016 11 | 3 | 0 | 3 |
| 2016 10 | 5 | 2 | 7 |
| 2016 8 | 2 | 1 | 3 |
| 2016 7 | 3 | 1 | 4 |
Show all
